Triptorelin (2mg)

Triptorelin is a synthetic peptide that is a gonadotropin-releasing hormone (GnRH) agonist analog. It is being researched for its potential to either stimulate or suppress hormone production in the hypothalamic-pituitary-gonadal (HPG) axis depending on the duration of exposure.

Product Information

Pricing

Chemical Makeup

Research and Clinical Studies

Hormonal Regulation

The primary area of research for Triptorelin is its potential to influence the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.

• Initial Upregulation: A single exposure to Triptorelin may potentially lead to a surge in LH and FSH release, which could temporarily enhance the synthesis of testosterone and estrogen. Researchers are investigating this for its potential to restore endogenous hormone production that may have been suppressed by other substances (5).

• Long-term Suppression: Prolonged or continuous exposure to Triptorelin is being researched for its potential to desensitize GnRH receptors. This downregulation of receptors may lead to a sustained decline in LH and FSH, which, in turn, may result in reduced testosterone and estrogen levels. This effect is being explored for its potential to treat conditions where hormone suppression is desired (6).

Immune System

Researchers are also exploring Triptorelin's potential to modulate the immune system. Studies on murine models suggest that GnRH-related peptides may interact with binding sites in the thymus, a key organ for T-cell development. This interaction is being investigated for its possible role in influencing immune function, particularly in the context of age-related immune decline (7).

Disclaimer: Triptorelin peptide is available for research and laboratory purposes only.